|
1 Company |
|
1 Product |
|
1 Product |
|
0 Mechanisms of Action |
|
0 Trials |
|
13 News |
|
- | Trial completion, Trial primary completion date: Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs). (clinicaltrials.gov) - Apr 23, 2018
P=N/A, N=409, Completed, Sponsor: Karolinska Institutet
Recruiting --> Completed | Trial primary completion date: Oct 2017 --> Jun 2017
- | Trial primary completion date: Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs). (clinicaltrials.gov) - Aug 21, 2017
P=N/A, N=500, Recruiting, Sponsor: Karolinska Institutet
Recruiting --> Completed | Trial primary completion date: Oct 2017 --> Jun 2017 Trial primary completion date: Jun 2017 --> Oct 2017
- |||| Privigen (human immune globulin intravenous 10%) / CSL Behring
Trial completion: INSTINCT: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial (clinicaltrials.gov) - Sep 30, 2016
P2, N=100, Completed, Sponsor: Anders Perner
Trial primary completion date: Jun 2017 --> Oct 2017 Active, not recruiting --> Completed
- ||| Privigen (human immune globulin intravenous 10%) / CSL Behring
Enrollment closed: INSTINCT: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial (clinicaltrials.gov) - Mar 4, 2016
P2, N=100, Active, not recruiting, Sponsor: Anders Perner
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Biomarker, Trial completion, Enrollment change, IO biomarker: BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections (clinicaltrials.gov) - Feb 17, 2016
P=N/A, N=169, Completed, Sponsor: Ole Hyldegaard
Recruiting --> Active, not recruiting Recruiting --> Completed | N=114 --> 169
- Biomarker, Trial primary completion date, IO biomarker: BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=114, Recruiting, Sponsor: Ole Hyldegaard
Recruiting --> Completed | N=114 --> 169 Trial primary completion date: Jul 2015 --> Feb 2016
- Biomarker, IO biomarker: BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections (clinicaltrials.gov) - Jul 3, 2014
P=N/A, N=114, Recruiting, Sponsor: Ole Hyldegaard
- Trial termination: Hyperglycemia in Surgical Infections (clinicaltrials.gov) - May 1, 2014
P=N/A, N=5, Terminated, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Jul 2015 --> Feb 2016 Completed --> Terminated; Difficulty in enrolling eligible patients
- ||||| Privigen (human immune globulin intravenous 10%) / CSL Behring
New P2 trial: INSTINCT: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial (clinicaltrials.gov) - Apr 9, 2014
P2, N=100, Recruiting, Sponsor: Anders Perner
- Enrollment change: Hyperglycemia in Surgical Infections (clinicaltrials.gov) - Mar 31, 2014
P=N/A, N=17, Completed, Sponsor: The University of Texas Health Science Center, Houston
Completed --> Terminated; Difficulty in enrolling eligible patients N=100 --> 17
- Trial completion: Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features (clinicaltrials.gov) - Nov 13, 2012
P=N/A, N=134, Completed, Sponsor: National Taiwan University Hospital
N=100 --> 17 Recruiting --> Completed